Trials in Baltimore, Maryland
Here are the top 10 medical studies for lung cancer in Baltimore, Maryland
Popular Filters
Phase 3 Trials
Chemotherapy
Radiation + Immunotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2 & 3
Washington, District of Columbia
This trial is testing the addition of radiation therapy to the usual immunotherapy (with or without chemotherapy) treatment for patients with non-small cell lung cancer that has spread to nearby tissue or lymph nodes (advanced) or has spread to other places in the body (metastatic) and who are also negative for a molecular marker called PD-L1.
Radiation Therapy
Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Brain Metastasis from Lung Cancer
Recruiting2 awardsPhase 3
Baltimore, Maryland
This trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus for the treatment of small cell lung cancer that has spread to the brain.
Immunostimulant
Combination Immunotherapy for Lung Cancer
Recruiting1 awardPhase 2 & 3
Washington, District of Columbia
This trial is testing a new combination of treatments for patients with advanced lung cancer. The treatments aim to boost the immune system's ability to fight cancer and prevent it from growing. The goal is to see if this combination can help patients live longer compared to standard treatments.
Trials With No Placebo
Medically Tailored Meals for Lung Cancer
Recruiting1 award7 criteria
Philadelphia, Pennsylvania
This trial is studying how well a nutrition intervention works in improving outcomes for patients with lung cancer who are economically disadvantaged, uninsured, racial and ethnic minorities, elderly, and/or rural residents.
Cytokine
NT-I7 + Atezolizumab for Lung Cancer
Recruiting1 awardPhase 2
Salisbury, Maryland
This trial will test the effectiveness of a new cancer treatment in people with squamous or non-squamous non-small cell lung cancer who haven't received prior systemic therapy. Up to 83 people will be enrolled in the study.
Monoclonal Antibodies
Tiragolumab + Atezolizumab + Bevacizumab for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Washington, District of Columbia
This trial will test whether combining tiragolumab with atezolizumab and bevacizumab is more effective than atezolizumab and bevacizumab alone in treating advanced non-squamous NSCLC.
Chemotherapy
Radiation + Immunotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2 & 3
Washington, District of Columbia
This trial is testing the addition of radiation therapy to the usual immunotherapy (with or without chemotherapy) treatment for patients with non-small cell lung cancer that has spread to nearby tissue or lymph nodes (advanced) or has spread to other places in the body (metastatic) and who are also negative for a molecular marker called PD-L1.
Monoclonal Antibodies
Pembrolizumab + Chemotherapy for Small Cell Lung Cancer
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial is testing new drugs combined with existing treatments and chemotherapy to see if they can better treat patients with severe, widespread lung cancer by boosting the immune system and enhancing chemotherapy effects.
Monoclonal Antibodies
SAR444245 + Pembrolizumab for Lung Cancer and Mesothelioma
Recruiting1 awardPhase 2
Philadelphia, Pennsylvania
This trial is testing a new drug called SAR444245 along with other cancer treatments in patients with tumors. The goal is to see if the drug can help shrink tumors and understand how it interacts with other treatments.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.